170 related articles for article (PubMed ID: 35480387)
21. Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins.
Morlieras J; Dufort S; Sancey L; Truillet C; Mignot A; Rossetti F; Dentamaro M; Laurent S; Vander Elst L; Muller RN; Antoine R; Dugourd P; Roux S; Perriat P; Lux F; Coll JL; Tillement O
Bioconjug Chem; 2013 Sep; 24(9):1584-97. PubMed ID: 23978076
[TBL] [Abstract][Full Text] [Related]
22. A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.
Durkan K; Jiang Z; Rold TL; Sieckman GL; Hoffman TJ; Bandari RP; Szczodroski AF; Liu L; Miao Y; Reynolds TS; Smith CJ
Nucl Med Biol; 2014 Feb; 41(2):133-9. PubMed ID: 24480266
[TBL] [Abstract][Full Text] [Related]
23. RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alphavbeta3-expressing endothelial cells.
Schraa AJ; Kok RJ; Botter SM; Withoff S; Meijer DK; de Leij LF; Molema G
Int J Cancer; 2004 Nov; 112(2):279-85. PubMed ID: 15352041
[TBL] [Abstract][Full Text] [Related]
24. Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates.
Schuster S; Juhász É; Halmos G; Neundorf I; Gennari C; Mező G
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563462
[TBL] [Abstract][Full Text] [Related]
25. Radiosynthesis, Biological Evaluation, and Preclinical Study of a
Pirooznia N; Abdi K; Beiki D; Emami F; Arab SS; Sabzevari O; Pakdin-Parizi Z; Geramifar P
Contrast Media Mol Imaging; 2020; 2020():8421657. PubMed ID: 32292304
[TBL] [Abstract][Full Text] [Related]
26. High-Affinity RGD-Knottin Peptide as a New Tool for Rapid Evaluation of the Binding Strength of Unlabeled RGD-Peptides to α
Bernhagen D; De Laporte L; Timmerman P
Anal Chem; 2017 Jun; 89(11):5991-5997. PubMed ID: 28492301
[TBL] [Abstract][Full Text] [Related]
27. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
28. Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice.
Lo WL; Lo SW; Chen SJ; Chen MW; Huang YR; Chen LC; Chang CH; Li MH
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064291
[TBL] [Abstract][Full Text] [Related]
29. Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion.
Villard V; Kalyuzhniy O; Riccio O; Potekhin S; Melnik TN; Kajava AV; Rüegg C; Corradin G
J Pept Sci; 2006 Mar; 12(3):206-12. PubMed ID: 16103993
[TBL] [Abstract][Full Text] [Related]
30. Bicyclic RGD Peptides with Exquisite Selectivity for the Integrin α
Bernhagen D; Jungbluth V; Quilis NG; Dostalek J; White PB; Jalink K; Timmerman P
ACS Comb Sci; 2019 Mar; 21(3):198-206. PubMed ID: 30624885
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of novel dual-cyclic RGD peptides for α
Liu J; Cheng X; Tian X; Guan D; Ao J; Wu Z; Huang W; Le Z
Bioorg Med Chem Lett; 2019 Apr; 29(7):896-900. PubMed ID: 30732943
[TBL] [Abstract][Full Text] [Related]
32. A Small Molecule-Drug Conjugate (SMDC) Consisting of a Modified Camptothecin Payload Linked to an α
Lerchen HG; Stelte-Ludwig B; Kopitz C; Heroult M; Zubov D; Willuda J; Schlange T; Kahnert A; Wong H; Izumi R; Hamdy A
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053556
[TBL] [Abstract][Full Text] [Related]
33. Discovery of VIP236, an αvβ3-Targeted Small-Molecule-Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors.
Lerchen HG; Stelte-Ludwig B; Heroult M; Zubov D; Gericke KM; Wong H; Frigault MM; Johnson AJ; Izumi R; Hamdy A
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686656
[TBL] [Abstract][Full Text] [Related]
34. Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering.
Guo Z; He B; Jin H; Zhang H; Dai W; Zhang L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2014 Jul; 35(23):6106-17. PubMed ID: 24794924
[TBL] [Abstract][Full Text] [Related]
35. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α
Raposo Moreira Dias A; Pina A; Dal Corso A; Arosio D; Belvisi L; Pignataro L; Caruso M; Gennari C
Chemistry; 2017 Oct; 23(58):14410-14415. PubMed ID: 28816404
[TBL] [Abstract][Full Text] [Related]
36. Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.
Sancey L; Lucie S; Garanger E; Elisabeth G; Foillard S; Stéphanie F; Schoehn G; Guy S; Hurbin A; Amandine H; Albiges-Rizo C; Corinne AR; Boturyn D; Didier B; Souchier C; Catherine S; Grichine A; Alexeï G; Dumy P; Pascal D; Coll JL; Jean-Luc C
Mol Ther; 2009 May; 17(5):837-43. PubMed ID: 19259068
[TBL] [Abstract][Full Text] [Related]
37. Selective interaction of a conformationally-constrained Arg-Gly-Asp (RGD) motif with the integrin receptor alphavbeta3 expressed on human tumor cells.
Lanza P; Felding-Habermann B; Ruggeri ZM; Zanetti M; Billetta R
Blood Cells Mol Dis; 1997 Aug; 23(2):230-41. PubMed ID: 9268674
[TBL] [Abstract][Full Text] [Related]
38. Integrin alphaVbeta3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly(ethylene imine).
Merkel OM; Germershaus O; Wada CK; Tarcha PJ; Merdan T; Kissel T
Bioconjug Chem; 2009 Jun; 20(6):1270-80. PubMed ID: 19476331
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3.
Yu YP; Wang Q; Liu YC; Xie Y
Biomaterials; 2014 Feb; 35(5):1667-75. PubMed ID: 24268666
[TBL] [Abstract][Full Text] [Related]
40. Characterisation of a novel, high affinity and selective αvβ6 integrin RGD-mimetic radioligand.
Hall ER; Bibby LI; Slack RJ
Biochem Pharmacol; 2016 Oct; 117():88-96. PubMed ID: 27501918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]